EPX Activators
The chemical class of EPX Activators comprises a diverse array of compounds that indirectly influence the activation of EPX through their action on eosinophil behavior and related inflammatory pathways. These activators do not directly interact with EPX but modulate various cellular and biochemical pathways that can lead to its activation. One primary mechanism of action for these chemicals is the modulation of inflammatory pathways and mediators. Chemicals like Zileuton, Montelukast, and Aspirin work by altering the levels of inflammatory mediators like leukotrienes or by modulating the inflammatory response, which in turn can influence eosinophil behavior and EPX activity. The alteration of these pathways can lead to a change in eosinophil activation, degranulation, or survival, all of which are crucial for the regulation of EPX activity.
Another significant mechanism involves the modulation of immune response pathways. Agents like Omalizumab, targeting specific elements of the allergic response, and natural compounds like Curcumin and Resveratrol, known for their broad-spectrum effects on inflammation and immunity, can indirectly impact eosinophil activity and, subsequently, EPX.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zileuton | 111406-87-2 | sc-204417 sc-204417A sc-204417B sc-204417C | 10 mg 50 mg 1 g 75 g | $84.00 $307.00 $369.00 $1254.00 | 8 | |
A 5-lipoxygenase inhibitor, Zileuton can modulate leukotriene production, a key factor in eosinophil activity. By altering leukotriene levels, it can influence eosinophil behavior and indirectly activate EPX. | ||||||
Montelukast Sodium | 151767-02-1 | sc-202231 sc-202231A sc-202231B | 10 mg 25 mg 250 mg | $51.00 $85.00 $161.00 | 5 | |
As a leukotriene receptor antagonist, Montelukast modulates eosinophil activation and degranulation, processes where EPX is involved. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid that influences eosinophil survival and activation. Dexamethasone's modulation of inflammatory responses can indirectly impact EPX activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
This natural compound has been shown to modulate various inflammatory pathways, potentially influencing eosinophil activity and consequently EPX activation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
A polyphenol that affects multiple signaling pathways, including those related to inflammation and immune response, potentially influencing EPX activity in eosinophils. | ||||||
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $42.00 | 4 | |
Known for its anti-inflammatory properties, Aspirin can modify eosinophil function and indirectly influence EPX activity. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $53.00 $88.00 | 6 | |
Another non-steroidal anti-inflammatory drug (NSAID) that can modulate inflammatory pathways and eosinophil activity, indirectly influencing EPX. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
A bronchodilator that also has anti-inflammatory effects, potentially affecting eosinophil activity and thereby EPX activation. | ||||||
Ginkgolide B | 15291-77-7 | sc-201037B sc-201037 sc-201037C sc-201037A | 5 mg 10 mg 25 mg 50 mg | $46.00 $64.00 $114.00 $201.00 | 8 | |
Extracted from Ginkgo biloba, this compound has been shown to affect eosinophil function, potentially influencing EPX activity. | ||||||